Covering Breast Cancer Awareness Month? Our experts are ready for your questions and coverage

Oct 1, 2021

2 min

Alicia Arnold, DO

October is Breast Cancer Awareness Month. Did you know that on average, every 2 minutes a woman is diagnosed with breast cancer in the United States.


And according to the National Breast Cancer Foundation:


  • In 2021, an estimated 281,550 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 49,290 new cases of non-invasive (in situ) breast cancer.


  • 63% of breast cancer cases are diagnosed at a localized stage (there is no sign that the cancer has spread outside of the breast), for which the 5-year survival rate is 99%.


  • This year, an estimated 43,600 women will die from breast cancer in the U.S.


  • Although rare, men get breast cancer too. In 2021, an estimated 2,650 men will be diagnosed with breast cancer this year in the U.S. and approximately 530 will die.


  • 1 in 8 women in the United States will be diagnosed with breast cancer in her lifetime


  • Breast cancer is the most common cancer in American women, except for skin cancers. It is estimated that in 2021, approximately 30% of all new women cancer diagnoses will be breast cancer.


  • There are over 3.8 million breast cancer survivors in the United States.



This year's theme is It's Time to Rise and the National Breast Cancer Foundation has a host of materials to watch and read for anyone looking to test themselves, find support or learn how they can help.



If you're a journalist looking to know more about this topic or if you are covering Breast Cancer Awareness month - then let our experts help with your stories.

 

Dr. Alicia Vinyard is a Board-Certified General Surgeon and Fellowship Trained Breast Surgical Oncologist at the Georgia Cancer Center and Medical College of Georgia at Augusta University. Dr. Vinyard is also an expert in breast cancer, cancer surgery and cancer survivorship. She is available to speak to media about Breast Cancer Awareness Month – simply click on her icon to now arrange an interview today.

Connect with:
Alicia Arnold, DO

Alicia Arnold, DO

Breast Surgical Oncologist

Dr. Alicia Arnold is an expert in breast cancer, cancer surgery and cancer survivorship.

CancerBreast CancerCancer SurvivorshipSurgical Oncology
Powered by

You might also like...

Check out some other posts from Augusta University

Augusta University's Simon Medcalfe on the Real Economics of Hosting the World Cup featured image

1 min

Augusta University's Simon Medcalfe on the Real Economics of Hosting the World Cup

With the World Cup underway across the U.S., Canada, and Mexico, Dr. Simon Medcalfe, economist at Augusta University's Hull College of Business, wrote for Augusta Business Daily about why FIFA's headline economic projections for the tournament don't hold up. His piece breaks down why most of the spending tied to hosting the event isn't new activity but rather it's money that would have been spent elsewhere regardless. As Medcalfe put it: "New spending is not created; it is just moved around." Read his full column in Augusta Business Daily :  Dr. Medcalfe is a Professor of Economics and Finance at Augusta University, with research spanning sports economics, community and economic development, and social determinants of health. He holds a PhD in Business/Managerial Economics from Lehigh University. If you're covering the economics of hosting major sporting events, public subsidies for host cities, or the gap between projected and actual tourism impact, Dr. Medcalfe is available for comment. Click on the contact button in his profile below. 

Can a Mother's ZIP Code Shape a Baby's Future? featured image

2 min

Can a Mother's ZIP Code Shape a Baby's Future?

Where an expectant mother lives might reveal important clues about her baby's health before birth. According to a recent Augusta University Jagwire article, researchers at the Medical College of Georgia have found that mapping birth outcomes by ZIP code can help identify communities where mothers and newborns face greater health risks, providing valuable information for healthcare providers and public health officials. The two-part study out of the Department of Anesthesiology and Perioperative Medicine at the Medical College of Georgia at Augusta University, led by Mary Arthur, MD, explored the relationship between neighborhood characteristics and neonatal outcomes. By combining geographic mapping with maternal and infant health data, the researchers identified areas with higher rates of adverse birth outcomes and examined how factors such as access to prenatal care and other social determinants of health might contribute to those disparities. The findings suggest that geographic data can become a valuable tool for improving maternal and infant health. By identifying communities at greater risk, healthcare systems and policymakers can better target prenatal education, outreach programs and healthcare resources to support expectant mothers before complications arise. For journalists covering maternal health, healthcare disparities and public policy, Arthur offers valuable insight into how community-level data can help guide interventions that improve pregnancy outcomes and give more babies a healthier start in life. "The maps make it very easy to visualize those ZIP codes that link to poor neonatal outcomes. They're also helpful for planning strategic interventions to help the people who live in those particular areas in terms of making sure there are outreach programs for mothers in those areas to have access to prenatal care." Mary Arthur, MD To learn more about this important research and connect with Mary Arthur, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Can One Gene Change the Future of Heart Disease? featured image

2 min

Can One Gene Change the Future of Heart Disease?

Heart disease remains the world's leading cause of death, but researchers are continuing to uncover the genetic mechanisms that drive it. According to a recent Augusta University Jagwire article highlighting new research, scientists are investigating how a little-studied gene might influence the development of cardiovascular disease and whether it could become a future target for treatment. At the center of the research is Kunzhe Dong, PhD, an investigator at Augusta University's Immunology Center of Georgia, who is examining the role of the SH3BGRL2 gene in cardiovascular cells. While the gene has previously been associated with cancer biology, early findings suggest it might also play an important role in regulating how blood vessels respond to stress and injury. Understanding that relationship could reveal new biological pathways involved in heart disease and identify novel opportunities for precision medicine. The research aims to determine how changes in gene expression affect the function of cardiovascular cells and contribute to disease progression. By better understanding these molecular mechanisms, scientists hope to identify new therapeutic targets and improve the ability to prevent or treat cardiovascular disease before irreversible damage occurs. The work also reflects a broader shift toward precision medicine, where treatments are tailored to the underlying biology of each patient rather than relying solely on traditional risk factors. "This gene is well known in one field, but now we're seeing it's also important in cardiovascular cells." Kunzhe Dong, PhD To learn more about this research and connect with Kunzhe Dong, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

View all posts